Yurogen Biosystems LLC
Yurogen Biosystems LLC, established in Boston in 2014, is a leading international biotech company specializing in monoclonal antibody development. With a commitment to innovation, the company utilizes its proprietary SMab platform to develop a diverse range of antibodies, including rabbit, llama, and human monoclonal antibodies for scientific research and drug development applications.
Since its expansion into East Asia with a branch in Wuhan, China, and a merger with ABclonal Science Inc. in 2021, Yurogen has successfully delivered over 2000 projects. The company offers extensive services in antibody discovery, engineering, and production to biotechnology and pharmaceutical companies worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.